Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010

<div>Odds ratio for hospitalized infection according to different biological disease-modifying antirheumatic drug. ETA: etanercept; TCZ: tocilizumab; ADA: adalimumab; IFX: infliximab; ABT: abatacept.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010 

Figure 2 | Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010 